OMGA Omega: Pangali Forward P/E
Omega Therapeutics is a leader in the field of epigenetic DNA reprogramming, bringing together the world's leading geneticists. The high authority of its management in mRNA therapy ensures the trust of major funds. The development of drugs for tissue regeneration is based on the OMEGA platform. The company's forward P/E for the coming year reflects market expectations, where the 0.00 metric determines the status of the current valuation parameter.
Rincian metrik keuangan lan pasar Omega Therapeutics Corp (OMGA)
- kuotasi lan prakiraan analis:
- data kapitalisasi saham perusahaan:
- informasi kapitalisasi buku:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Omega Therapeutics|OMGA - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Omega Therapeutics|OMGA - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Omega Therapeutics Inc|OMGA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Omega Therapeutics|Likuiditas cepet omegatherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
OMGA - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Omega Therapeutics|OMGA - Kapitalisasi marang bathi|Prakiraan rega marang bathi Omega|OMGA - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Omega Therapeutics Inc|OMGA - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Omega Therapeutics|OMGA - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan omegatherapeutics.com|OMGA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Omega Therapeutics
Analisis kabeh metrik perusahaan:OMGA Omega Therapeutics, Inc.
For Omega Therapeutics (OMGA), which is developing epigenetic programming via the OMEGA platform, the company's forward P/E ratio serves as an indicator of market expectations regarding the future monetization of its oncology developments. This multiple is calculated as the ratio of the current share price to the expected net income for the following year, allowing investors to assess the premium paid for the future success of the biotechnology business.
Pesaing langsung
Pangali Forward P/E TEM|Qiagen NV (QGEN) - Pangali forward rega marang bathi|Pangali Forward P/E IONS (Ionis Pharma)|Pangali Forward P/E Repligen Inc. RGEN|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (crisprtx.com)|WGS (GeneDx) - Prakiraan rega marang bathi|RARE: Rasio kapitalisasi marang bathi mangsa ngarep|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TWST|TXG - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Intellia Therapeutics, Inc. NTLA|Pangali mangsa ngarep rega marang bathi STOK|BioLife Corp - Pangali Forward P/E|WVE - Pangali Forward P/E|Maze Therapeutics Inc (MAZE) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake SION (sionnatx.com)|PRME (Prime Medicine) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Taysha Gene Therapies Inc TSHA|Prakiraan rega marang bathi QURE (uniQure Corp)|Pangali Forward P/E MeiraGTx Corp (MGTX)|REGENXBIO Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep SLDB (solidbio.com)|Ocugen - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Pacific Biosciences of California, Inc. PACB|BNTC: Pangali Forward P/E|Prakiraan rega marang bathi Design Corp|Rega marang bathi mangsa ngarep Rocket Pharmaceuticals|4dmoleculartherapeutics.com (FDMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Lexeo Therapeutics (LXEO)|KRRO - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Editas EDIT|SLN - Prakiraan rega marang bathi|ProQR Therapeutics NV - Pangali Forward P/E|Pangali forward rega marang bathi Codexis, Inc. (CDXS)|SGMO: Pangali Forward P/E|Nautilus Bio (NAUT) - Pangali Forward P/E|MGX (Metagenomi, Inc) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep DTIL (Precision BioSciences Inc.)|Rega marang bathi mangsa ngarep Generation Bio Co. (GBIO)|boundlessbio.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E XCUR (Exicure)|Pangali Forward P/E Imunon Inc IMNN|PHIO - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Mustang Bio, Inc.|transcodetherapeutics.com (RNAZ) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Bionano Genomics|APDN (Applied DNA Sciences, Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi bluebird bio Inc. BLUE|Pangali Forward P/E IPA|Singular Genomics Corp (OMIC) - Pangali forward rega marang bathi|Pangali Forward P/E RGLS (Regulus Therapeutics)|Pangali Forward P/E syros.com SYRS|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON Pharmaceuticals Inc.)|UBX (Unity Bio) - Prakiraan rega marang bathi
